A Novel and Sustainable HPLC Method for Monitoring Mutagenic Impurity in Injectable Medicines and Raw Ingredients via Microscale Preparation: Assessment via Greenness Tools
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Ahmed Sobhy Darwish und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt. Hauptthemen laut MEDLINE: Mutagens, Drug Contamination. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia.
Abstract (Originalsprache)
The goal of the presented methodology was to evolve and verify a simple, environmentally friendly, white HPLC stability‐indicating technology that can identify the mutagenic contaminant allyl bromide in both raw materials and parenteral rocuronium bromide medications. The mobile phase composition was ethyl alcohol and double‐distilled water in a ratio of 35%:65% at a flow rate of 1.0 mL/min. The linearity range concentrations of allyl bromide were 1.25–10 μg/mL. The injectable volume was 20 μL, and the injection run time and total run time were less than 9 min. With a retention time of allyl bromide at 7.11 min, the detection wavelength was 210 nm. The method's BAGI degree was 77.5, the MoGAPI degree was 82 with seven green sections, the final AES degree was 87, the AGSA degree was 80.56, the CaFRI degree was 86, the CACI degree was 77, and the whiteness score was 97.1. The HPLC method features simple implementation, environmental sustainability, and compliance with ICH Q2(R2), ICH M7, and US FDA validation criteria. It offers advantages like shorter retention time, reduced reagent use, microscale sample preparation, and lower costs compared to complex systems like UPLC‐MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt.
- EIPICO, Egyptian International Pharmaceutical Industries Company, 10th of Ramadan City, Egypt.
- Department of Public Health, College of Veterinary Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
- Department of Agribusiness and Consumer Sciences, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa, Saudi Arabia.
- Department of Anatomy, College of Medicine, King Khalid University, Abha, Saudi Arabia.
- Department of Food Hygiene, Safety abd Technology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
ORCID-Profile: Ahmed Sobhy Darwish, Sherief M Abdel-Raheem, Mahmoud Samir A Zaki
Förderung
- Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia
Zitieren
APA
Darwish, A. S., Abdel-Raheem, S. M., Ismail, H., Ameen, F. A., Zaki, M. S. A., & Darwish, W. S. (2026). A Novel and Sustainable HPLC Method for Monitoring Mutagenic Impurity in Injectable Medicines and Raw Ingredients via Microscale Preparation: Assessment via Greenness Tools. Biomedical Chromatography. https://doi.org/10.1002/bmc.70418
Vancouver
Darwish AS, Abdel-Raheem SM, Ismail H, Ameen FA, Zaki MSA, Darwish WS. A Novel and Sustainable HPLC Method for Monitoring Mutagenic Impurity in Injectable Medicines and Raw Ingredients via Microscale Preparation: Assessment via Greenness Tools. Biomedical Chromatography. 2026. doi:10.1002/bmc.70418
BibTeX
@article{Darwish2026,
author = {Darwish, Ahmed Sobhy and Abdel-Raheem, Sherief M and Ismail, Hesham and Ameen, Faleh A and Zaki, Mahmoud Samir A and Darwish, Wageh Sobhy},
title = {A Novel and Sustainable HPLC Method for Monitoring Mutagenic Impurity in Injectable Medicines and Raw Ingredients via Microscale Preparation: Assessment via Greenness Tools},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70418}
}
EUVIMED